REVAMP Clinical Trial Dataset Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa

Domain:

healthcare

Record type:

dataset

Creator:

Mar

Editor:

Sie

Publisher:

Har

Host:

Data are derived from the Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa (REVAMP) clinical trial. The de-identified dataset includes include randomization allocation, baseline participant characteristics and primary and secondary outcomes.

Visit

doi.org dataverse.harvard.edu

Licenses

info:eu-repo/semantics/openAccess Custom terms specific to this dataset https://dataverse.harvard.edu/api/datasets/:persistentId/versions/1.0/customlicense?persistentId=doi:10.7910/DVN/SKUUOP

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.

Increased provision of antiretroviral therapy in sub-Saharan Africa has led to a growing number of p

Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?

OBJECTIVE: Higher than expected pregnancy rates have been observed in HIV related clinical trials in

Addressing Pediatric HIV Pretreatment Drug Resistance and Virologic Failure in Sub-Saharan Africa: A Cost-Effectiveness Analysis of Diagnostic-Based Strategies in Children ≥3 Years Old

Improvement of antiretroviral therapy (ART) regimen switching practices and implementation of pretre

Detection of HIV Virologic Failure and Switch to Second-Line Therapy: A Systematic Review and Meta-analysis of Data From Sub-Saharan Africa

Abstract Background The late recognition of

Data Challenge: Clinical Burden of Antimicrobial Resistance in Sub-Saharan Africa

Antimicrobial resistance (AMR) is increasingly recognize and pose a major threat to global health sy

High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali

Background: Limited data exist on drug resistance and antiretroviral treatment (ART) o